Skip to Content
Trade options on Composer. Earn up to $200 in cash rebates!Get Started.T&Cs apply.
Symphonies
V1 Biotech BlackSwanCatcher K-1 Free
Today’s Change
—

A symphony is an automated trading strategy — Learn more about symphonies here

About

Tactical biotech: ride uptrends with BIB (2x), short extreme spikes with BIS (−2x), and shift to defensive sectors, gold, and the U.S. dollar when volatility rises. Uses simple heat, trend, drawdown, and volatility checks to switch.
NutHow it works
This is a biotech‑focused switcher. • Risk‑on: buy BIB (a 2x biotech fund) when the trend is up or after deep oversold. • Fade extremes: use BIS (a −2x biotech fund) when biotech is red‑hot or on sharp bounces after a crash. • Risk‑off: rotate into 2–3 defensive sector funds (health care, utilities, staples), plus gold (GLD) and/or the U.S. dollar (USDU) when recent drops or bond turbulence appear. It judges heat (RSI), short‑term average, drop from recent high (drawdown), and choppiness (volatility).
CheckmarkValue prop
Out-of-sample, this biotech-tactical strategy targets ~35.6% annual return with ~1.22 Sharpe and ~0.93 Calmar, potentially outperforming SPY on risk-adjusted terms; positive alpha, but higher drawdowns (~38% vs ~19%).
1M
3M
6M
YTD
1Y
3Y
Max
www.composer.trade
Performance
Compared to selected benchmarks
AlphaBetaR2R
SPY
0.350.640.130.36
Performance Metrics
Cumulative ReturnAnnualized ReturnTrailing 1M ReturnTrailing 3M ReturnSharpe Ratio
SPY
305.71%14.66%2.19%5.01%0.85
V1 Biotech BlackSwanCatcher K-1 Free
5,921.68%49.25%3.95%16.55%1.41
Initial Investment
$10,000.00
Final Value
$602,168.03
Regulatory Fees
$3,706.37
Total Slippage
$23,249.80
Invest in this strategy
OOS Start Date
Aug 6, 2023
Trading Setting
Threshold 10%
Type
Stocks
Category
Biotech, tactical rotation, leveraged etfs, long/short, momentum, mean reversion, risk-off rotation, defensive sectors, gold, u.s. dollar
Tickers in this symphonyThis symphony trades 16 assets in total
Ticker
Type
BIB
ProShares Ultra NASDAQ Biotechnology
Stocks
BIS
ProShares UltraShort NASDAQ Biotechnology
Stocks
BND
Vanguard Total Bond Market
Stocks
GLD
SPDR Gold Trust, SPDR Gold Shares
Stocks
IEF
iShares 7-10 Year Treasury Bond ETF
Stocks
TLT
iShares 20+ Year Treasury Bond ETF
Stocks
TMF
Direxion Daily 20+ Year Treasury Bull 3X Shares (based on the NYSE 20 Year Plus Treasury Bond Index; symbol AXTWEN)
Stocks
USDU
WisdomTree Bloomberg U.S. Dollar Bullish Fund
Stocks
XBI
State Street SPDR S&P Biotech ETF
Stocks
XLB
State Street Materials Select Sector SPDR ETF
Stocks

FAQ

A Composer symphony is an automated trading strategy that executes trades based on parameters of your choice. Some symphonies are similar to holding one ETF in normal conditions and rotating to a different ETF when market conditions shift, for example a 5% drop in the S&P 500, while others use complex rules with dozens of triggers. However, complex doesn’t always mean better. A simple, well-structured symphony can be just as effective as an intricate one. Learn more about how symphonies work here.

"V1 Biotech BlackSwanCatcher K-1 Free" is currently performing the same as yesterday today. Performance updates in real time during market hours.

"V1 Biotech BlackSwanCatcher K-1 Free" is currently allocated toUSDU, XLEandGLD. Holdings automatically adjust as market conditions change based on the strategy's rules.

Year-to-date, "V1 Biotech BlackSwanCatcher K-1 Free" has returned 35.60%. You can adjust the performance chart above to view returns across different time horizons.

The maximum drawdown for "V1 Biotech BlackSwanCatcher K-1 Free" is 38.45%. The maximum drawdown measures the largest peak-to-trough decline. It's an important metric to evaluate risk and the strategy's behavior during market stress.

To invest in "V1 Biotech BlackSwanCatcher K-1 Free", simply click the Invest button on this page. You'll need to open an account with Composer if you don't have one yet, then you can start investing. Composer will automatically execute the trades for you based on the strategy's rules. Composer also supports trading individual stocks, ETFs, crypto, and options.